Renan Amador
Rheumatology · Margate, FLNPI 1487219721
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,243 and has fallen 62.0% since, to $473 in 2025. That places this record below the midpoint for rheumatology clinicians in FL, where the typical reported total is $6,335.
Across 85 payments — averaging $32.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$427
- AstraZeneca$365
- Mallinckrodt Hospital Products Inc.$334
- UCB, Inc.$261
- Amgen$247
- Aurinia Pharma U.S., Inc.$207
- plus $918 from 15 others
What the payments were for
- Food & beverage$2,66196%
- Education$994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $427 |
| AstraZeneca(2 entities) | 7 | $365 |
| Mallinckrodt Hospital Products Inc. | 11 | $334 |
| UCB, Inc. | 8 | $261 |
| Amgen | 11 | $247 |
| Aurinia Pharma U.S., Inc. | 8 | $207 |
| Sanofi | 2 | $187 |
| Lilly USA, LLC | 3 | $112 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| E.r. Squibb & Sons, L.L.C. | 3 | $77 |
| Boehringer Ingelheim | 1 | $74 |
| Pfizer | 3 | $63 |
| Sobi, Inc | 3 | $57 |
| Novartis | 2 | $52 |
| Scilex Pharmaceuticals Inc. | 2 | $48 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $28 |
| Johnson & Johnson | 1 | $25 |
| Alvogen Inc | 1 | $25 |
| Fresenius Kabi USA, LLC | 1 | $24 |
| Octapharma USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,760 in reported general payments places this provider in the 35th percentile of 453 rheumatology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 16 | $166 |
| MethotrexateMethotrexate Sodium | 17 | $150 |
| Prednisone | 21 | $143 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 15 | $69 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Margate
- Jigar ShahMargate$750K
- Alvin WellsDestin$2.4M
- Guillermo ValenzuelaPlantation$1.5M
- Julio Gonzalez-PaoliTampa$1.4M
- Ernesto RodriguezZephyrhills$958K
- Vinicius Costa Diniz DominguesDaytona Beach$921K
- Jonathan GreerBoynton Beach$757K
- Rachel TateHollywood$729K
- Howard BuschLoxahatchee$717K
- Michael WeitzMiami$658K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.